Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Shimoni, Avichai  [Clear All Filters]
2019
Shimoni, A., Labopin, M., Savani, B., Byrne, M., Volin, L., Finke, J., Niederwieser, D., Ehninger, G., Blaise, D., Beelen, D., et al. (2019). Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT.Biol Blood Marrow Transplant.
Nagler, A., Labopin, M., Dholaria, B., Finke, J., Brecht, A., Schanz, U., Niittyvuopio, R., Neubauer, A., Bornhäuser, M., Santarone, S., et al. (2019). Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.Br J Haematol.
2018
Shimoni, A., Labopin, M., Lorentino, F., van Lint, M.Teresa, Koc, Y., Gulbas, Z., Tischer, J., Bruno, B., Blaise, D., Pioltelli, P., et al. (2018). Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia.
2016
van Gorkom, G., Finel, H., Giebel, S., Pohlreich, D., Shimoni, A., Ringhoffer, M., Sucak, G., Schaap, N., Dreger, P., Sureda, A., et al. (2016). Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.J Clin Apher.
Shimoni, A., and Zwas, S.Tzila (2016). Radioimmunotherapy and Autologous Stem-Cell Transplantation in the Treatment of B-Cell Non-Hodgkin Lymphoma.Semin Nucl Med46, 119-125.
2014
Mei, M., Wondergem, M.J., Palmer, J.M., Shimoni, A., Hasenkamp, J., Tsai, N.-C., Simpson, J., Nademanee, A., Raubitschek, A., Forman, S.J., et al. (2014). Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimen.Biol Blood Marrow Transplant.
Shem-Tov, N., Labopin, M., Moukhtari, L., Ciceri, F., Esteve, J., Giebel, S., Gorin, N.-C., Schmid, C., Shimoni, A., Nagler, A., et al. (2014). Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Oncologist.
2013
Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., et al. (2013). Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen--A Report From the Acute Leukemia Worki.J Clin Oncol.
Michael, M., Shimoni, A., and Nagler, A. (2013). Regulatory T Cells in Allogeneic Stem Cell Transplantation.Clin Dev Immunol2013, 608951.
Resnick, I.B., Barkats, C., Shapira, M.Y., Stepensky, P., Bloom, A.I., Shimoni, A., Mankuta, D., Varda-Bloom, N., Rheingold, L., Yeshurun, M., et al. (2013). Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).Am J Blood Res3, 225-38.